AAAAAA

   
Results: 1-21 |
Results: 21
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporterphenotype in humans
Authors: Martinez, D Gelernter, J Abi-Dargham, A van Dyck, CH Kegeles, L Innis, RB Laruelle, M
Citation: D. Martinez et al., The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporterphenotype in humans, NEUROPSYCH, 24(5), 2001, pp. 553-560
Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: A dose-occupancy study with [C-11]WAY 100635 and positron emission tomography in humans
Authors: Martinez, D Hwang, DR Mawlawi, O Slifstein, M Kent, J Simpson, N Parsey, RV Hashimoto, T Huang, YY Shinn, A Van Heertum, R Abi-Dargham, A Caltabiano, S Malizia, A Cowley, H Mann, JJ Laruelle, M
Citation: D. Martinez et al., Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: A dose-occupancy study with [C-11]WAY 100635 and positron emission tomography in humans, NEUROPSYCH, 24(3), 2001, pp. 209-229
"Functional" neuroreceptor imaging - The example of studies of synaptic dopamine activity with single photon emission computed tomography
Authors: Lombardo, I Abi-Dargham, A Kegeles, L Laruelle, M
Citation: I. Lombardo et al., "Functional" neuroreceptor imaging - The example of studies of synaptic dopamine activity with single photon emission computed tomography, PSYCHIATRIC NEUROIMAGING RESEARCH: CONTEMPORARY STRATEGIES, 2001, pp. 207-232
Positron emission tomography study of pindolol occupancy of 5-HT1A receptors in humans: Preliminary analyses
Authors: Martinez, D Mawlawi, O Hwang, DR Kent, J Simpson, N Parsey, RV Hashimoto, T Slifstein, M Huang, YY Van Heertum, R Abi-Dargham, A Caltabiano, S Malizia, A Cowley, H Mann, JJ Laruelle, M
Citation: D. Martinez et al., Positron emission tomography study of pindolol occupancy of 5-HT1A receptors in humans: Preliminary analyses, NUCL MED BI, 27(5), 2000, pp. 523-527
Cortical inhibition in alcohol dependence
Authors: Taber, KH Hurley, RA Abi-Dargham, A Porjesz, B
Citation: Kh. Taber et al., Cortical inhibition in alcohol dependence, J NEUROP CL, 12(2), 2000, pp. 173-176
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-C-11]WAY-100635 in humans: Comparison of arterial and reference tissue input functions
Authors: Parsey, RV Slifstein, M Hwang, DR Abi-Dargham, A Simpson, N Mawlawi, O Guo, NN Van Heertum, R Mann, JJ Laruelle, M
Citation: Rv. Parsey et al., Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-C-11]WAY-100635 in humans: Comparison of arterial and reference tissue input functions, J CEREBR B, 20(7), 2000, pp. 1111-1133
Measurement of striatal and extrastriatal dopamine D-1 receptor binding potential with [C-11]NNC 112 in humans: Validation and reproducibility
Authors: Abi-Dargham, A Martinez, D Mawlawi, O Simpson, N Hwang, DR Slifstein, M Anjilvel, S Pidcock, J Guo, NN Lombardo, I Mann, JJ Van Heertum, R Foged, C Halldin, C Laruelle, M
Citation: A. Abi-dargham et al., Measurement of striatal and extrastriatal dopamine D-1 receptor binding potential with [C-11]NNC 112 in humans: Validation and reproducibility, J CEREBR B, 20(2), 2000, pp. 225-243
In vivo quantification of brain serotonin transporters in humans using [C-11]McN 5652
Authors: Parsey, RV Kegeles, LS Hwang, DR Simpson, N Abi-Dargham, A Mawlawi, O Slifstein, M Van Heertum, RL Mann, JJ Laruelle, M
Citation: Rv. Parsey et al., In vivo quantification of brain serotonin transporters in humans using [C-11]McN 5652, J NUCL MED, 41(9), 2000, pp. 1465-1477
Increased baseline occupancy of D-2 receptors by dopamine in schizophrenia
Authors: Abi-Dargham, A Rodenhiser, J Printz, D Zea-Ponce, Y Gil, R Kegeles, LS Weiss, R Cooper, TB Mann, JJ Van Heertum, RL Gorman, JM Laruelle, M
Citation: A. Abi-dargham et al., Increased baseline occupancy of D-2 receptors by dopamine in schizophrenia, P NAS US, 97(14), 2000, pp. 8104-8109
Modulation of amphetamine-induced striatal dopamine release by ketamine inhumans: Implications for schizophrenia
Authors: Kegeles, LS Abi-Dargham, A Zea-Ponce, Y Rodenhiser-Hill, J Mann, JJ Van Heertum, RL Cooper, TB Carlsson, A Laruelle, M
Citation: Ls. Kegeles et al., Modulation of amphetamine-induced striatal dopamine release by ketamine inhumans: Implications for schizophrenia, BIOL PSYCHI, 48(7), 2000, pp. 627-640
Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [I-123]beta-CIT
Authors: Laruelle, M Abi-Dargham, A van Dyck, C Gil, R D'Souza, DC Krystal, J Seibyl, J Baldwin, R Innis, R
Citation: M. Laruelle et al., Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [I-123]beta-CIT, BIOL PSYCHI, 47(5), 2000, pp. 371-379
Dissociation of ketamine effects on rule acquisition and rule implementation: Possible relevance to NMDA receptor contributions to executive cognitive functions
Authors: Krystal, JH Bennett, A Abi-Saab, D Belger, A Karper, LP D'Souza, DC Lipschitz, D Abi-Dargham, A Charney, DS
Citation: Jh. Krystal et al., Dissociation of ketamine effects on rule acquisition and rule implementation: Possible relevance to NMDA receptor contributions to executive cognitive functions, BIOL PSYCHI, 47(2), 2000, pp. 137-143
Low dopamine D-2 receptor binding potential in social phobia
Authors: Schneier, FR Liebowitz, MR Abi-Dargham, A Zea-Ponce, Y Lin, SH Laruelle, M
Citation: Fr. Schneier et al., Low dopamine D-2 receptor binding potential in social phobia, AM J PSYCHI, 157(3), 2000, pp. 457-459
Serotonin receptors as targets of antipsychotic medications
Authors: Abi-Dargham, A Krystal, J
Citation: A. Abi-dargham et J. Krystal, Serotonin receptors as targets of antipsychotic medications, PHARM TOXIC, 2000, pp. 79-107
Interactive effects of subanesthetic ketamine and haloperidol in healthy humans
Authors: Krystal, JH D'Souza, DC Karper, LP Bennett, A Abi-Dargham, A Abi-Saab, D Cassello, K Bowers, MB Vegso, S Heninger, GR Charney, DS
Citation: Jh. Krystal et al., Interactive effects of subanesthetic ketamine and haloperidol in healthy humans, PSYCHOPHAR, 145(2), 1999, pp. 193-204
[I-123]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia
Authors: Verhoeff, NPLG Soares, JC D'Souza, CD Gil, R Degen, K Abi-Dargham, A Zoghbi, SS Fujita, M Rajeevan, N Seibyl, JP Krystal, JH van Dyck, CH Charney, DS Innis, RB
Citation: Nplg. Verhoeff et al., [I-123]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia, PSYCH RES-N, 91(3), 1999, pp. 163-173
No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia
Authors: Abi-Dargham, A Laruelle, M Krystal, J D'Souza, C Zoghbi, S Baldwin, RM Seibyl, J Mawlawi, O de Erasquin, G Charney, D Innis, RB
Citation: A. Abi-dargham et al., No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia, NEUROPSYCH, 20(6), 1999, pp. 650-661
PET studies of binding competition between endogenous dopamine and the D-1radiotracer [C-11]NNC 756
Authors: Abi-Dargham, A Simpson, N Kegeles, L Parsey, R Hwang, DR Anjilvel, S Zea-Ponce, Y Lombardo, I Van Heertum, R Mann, JJ Foged, C Halldin, C Laruelle, M
Citation: A. Abi-dargham et al., PET studies of binding competition between endogenous dopamine and the D-1radiotracer [C-11]NNC 756, SYNAPSE, 32(2), 1999, pp. 93-109
Stability of [I-123]IBZM SPECT measurement of amphetamine-induced striataldopamine release in humans
Authors: Kegeles, LS Zea-Ponce, Y Abi-Dargham, A Rodenhiser, J Wang, T Weiss, R Van Heertum, RL Mann, JJ Laruelle, M
Citation: Ls. Kegeles et al., Stability of [I-123]IBZM SPECT measurement of amphetamine-induced striataldopamine release in humans, SYNAPSE, 31(4), 1999, pp. 302-308
Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans
Authors: Fujita, M Woods, SW Verhoeff, NPLG Abi-Dargham, A Baldwin, RM Zoghbi, SS Soares, JC Jatlow, PA Krystal, JH Rajeevan, N Charney, DS Seibyl, JP Innis, RB
Citation: M. Fujita et al., Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans, EUR J PHARM, 368(2-3), 1999, pp. 161-172
Increased dopamine transmission in schizophrenia: Relationship to illness phases
Authors: Laruelle, M Abi-Dargham, A Gil, R Kegeles, L Innis, R
Citation: M. Laruelle et al., Increased dopamine transmission in schizophrenia: Relationship to illness phases, BIOL PSYCHI, 46(1), 1999, pp. 56-72
Risultati: 1-21 |